Name: UMIN ID:
Unique ID issued by UMIN | UMIN000038683 |
---|---|
Receipt number | R000044061 |
Scientific Title | Real-world observational study on the efficacy and safety of first-line osimertinib treatment and on post-progression patterns of care in patients with epidermal growth factor receptor activating mutation positive (EGFRm +) advanced non-small-cell lung cancer (NSCLC) -Reiwa- |
Date of disclosure of the study information | 2019/11/26 |
Last modified on | 2019/11/25 16:01:43 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/11/25 16:02:21 |